Joan Albert Barberà

1990–2025 年に発表

別表記
Joan-Albert Barberà
129
論文数
29,113
被引用数
84
h 指数
125
i10 指数

被引用数

Joan Albert Barberà の年別被引用数1991 年: 被引用 3 件1992 年: 被引用 1 件1993 年: 被引用 1 件1994 年: 被引用 8 件1995 年: 被引用 1 件1996 年: 被引用 9 件1997 年: 被引用 19 件1998 年: 被引用 11 件1999 年: 被引用 26 件2000 年: 被引用 28 件2001 年: 被引用 51 件2002 年: 被引用 39 件2003 年: 被引用 88 件2004 年: 被引用 58 件2005 年: 被引用 95 件2006 年: 被引用 90 件2007 年: 被引用 78 件2008 年: 被引用 93 件2009 年: 被引用 133 件2010 年: 被引用 155 件2011 年: 被引用 164 件2012 年: 被引用 273 件2013 年: 被引用 251 件2014 年: 被引用 235 件2015 年: 被引用 217 件2016 年: 被引用 222 件2017 年: 被引用 171 件2018 年: 被引用 179 件2019 年: 被引用 625 件2020 年: 被引用 655 件2021 年: 被引用 645 件2022 年: 被引用 580 件2023 年: 被引用 448 件2024 年: 被引用 1,013 件2025 年: 被引用 325 件2026 年: 被引用 10 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,931 件、この内訳の 20.6%イギリス: 引用元論文 793 件、この内訳の 8.4%ドイツ: 引用元論文 658 件、この内訳の 7%イタリア: 引用元論文 544 件、この内訳の 5.8%中国: 引用元論文 531 件、この内訳の 5.6%フランス: 引用元論文 513 件、この内訳の 5.5%スペイン: 引用元論文 492 件、この内訳の 5.2%カナダ: 引用元論文 420 件、この内訳の 4.5%オランダ: 引用元論文 392 件、この内訳の 4.2%スイス: 引用元論文 288 件、この内訳の 3.1%日本: 引用元論文 282 件、この内訳の 3%ベルギー: 引用元論文 280 件、この内訳の 3%
0%20.6%その他 24.1%

分野

  • Medicine89.7%
  • Biochemistry, Genetics and Molecular Biology5.8%
  • Engineering1%
  • Immunology and Microbiology0.8%
  • Environmental Science0.6%
  • Neuroscience0.5%
  • その他1.6%

トピック

  • Pulmonary Hypertension Research and Treatments17.6%
  • Chronic Obstructive Pulmonary Disease (COPD) Research8.9%
  • Cardiovascular Function and Risk Factors4.5%
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis3.7%
  • Respiratory Support and Mechanisms3.1%
  • Heart Failure Treatment and Management2.8%
  • その他59.4%

共著者

全論文

検索で開く
  1. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Markus Schwerzmann, Anh Tuan Dinh‐Xuan, Andy Bush, Magdy Abdelhamid, Victor Aboyans, Eloisa Arbustini, Riccardo Asteggiano, Joan Albert Barberà, Maurice Beghetti, Jelena Čelutkienė, Maja Čikeš, Robin Condliffe, Frances S. de Man, Volkmar Falk, Laurent Fauchier, Seán Gaine, Nazzareno Galiè, Wendy Gin‐Sing, John Granton, Ekkehard Grünig, Paul M. Hassoun, Merel E. Hellemons, Tiny Jaarsma, Barbro Kjellström, Frederikus A. Klok, А. О. Конради, Konstantinos C. Koskinas, Dipak Kotecha, Iréne Lang, Basil S. Lewis, Aleš Linhart, Gregory Y H Lip, Maja Lisa Løchen, Alexander G. Mathioudakis, Richard Mindham, Shahin Moledina, Robert Naeije, Jens Cosedis Nielsen, Horst Olschewski, Isabelle Opitz, Steffen E. Petersen, Eva Prescott, Amina Rakisheva, Abílio Reis, Arsen Ristić, Nicolás Roche, Rita Rodrigues, Christine Selton‐Suty, Rogério Souza, Andrew J. Swift, Rhian M. Touyz, Silvia Ulrich, Martin R. Wilkins, Stephen J. Wort - European Heart Journal 2022 被引用: 3,652

  2. Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension

    著者: , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2015 被引用: 1,158

  3. Pulmonary hypertension in chronic lung disease and hypoxia

    著者: , , , , , , , , , , , - European Respiratory Journal 2018 被引用: 761

  4. Chronic Thromboembolic Pulmonary Hypertension (CTEPH)

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Circulation 2011 被引用: 1,049

  5. Long-Term Outcome of Patients With Chronic Thromboembolic Pulmonary Hypertension

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Circulation 2016 被引用: 666

  6. Pulmonary vascular endothelium: the orchestra conductor in respiratory diseases

    著者: , , , , , , , , , , , , , , , , , - European Respiratory Journal 2018 被引用: 214

  7. Pulmonary Vascular Involvement in Chronic Obstructive Pulmonary Disease. Is There a Pulmonary Vascular Phenotype?

    著者: , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2018 被引用: 209

  8. Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jaquelina O. Arakaki, G. Meyer, Rogério Souza, David Langleben, Hikmet Al‐Hiti, Pavel Jansa, Søren Mellemkjær, Fabrice Bauer, David Montani, Gérald Simonneau, Daniel Drömann, H-A Ghofrani, Ekkehard Grünig, Michael Halank, Matthias Held, Marius M. Hoeper, Hans Klose, Nikolaus Kneidinger, Hanno Leuchte, Christian Opitz, Stephan Rosenkranz, Heinrike Wilkens, Hubert Wirtz, Haralampos Karvounis, Georgia Pitsiou, Stylianos E. Orfanos, Michael D’Alto, Stefano Ghio, CD Vizza, Patrizio Vitulo, T. Nakayama, Hisataka Maki, Shunsuke Tatebe, Manuel Ibarra, Tomás Pulido, Arie P.J. van Dijk, Anton Vonk Noordegraaf, Tomasz Roleder, G. Castro, MJ Loureiro, Susana Robalo-Martins, Joan Albert Barberà, M Lázaro, GM Perez-Penate, Antonio Román, C-C Cheng, C-H. Hsu, H-H Hsu, Erhan Atahan, N Mogulkoc Bishop, NG Okumus, Zeynep Pınar Önen, Chang Hj, S-A Chang, Jin Sun Lee, H-K Kim, JG Coghlan, PA Corris, Colin Church, Robin Condliffe, J. Simon R. Gibbs, AJ Peacock, Stephen J. Wort, Roblee P. Allen, Samuel A. Allen, Rana Awdish, RL Benza, Shilpa A. DeSouza, Jeremy Feldman, Shilpa Johri ほか 12 名 - The Lancet Respiratory Medicine 2021 被引用: 161

  9. Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Bogdan A. Popescu, Z. Reiner, U. Sechtem, P. A. Sirnes, Michał Tendera, P. Vardas, Petr Widimský, Document Reviewers, U. Sechtem, N. Al Attar, Felicita Andreotti, M. Aschermann, Riccardo Asteggiano, Raymond L. Benza, Rolf M.F. Berger, Dominique Bonnet, Marion Delcroix, Luke Howard, Anastasia Kitsiou, Iréne Lang, Aldo P. Maggioni, Jens Erik Nielsen‐Kudsk, M. Park, Pasquale Perrone Filardi, Susanna Price, María Teresa Subirana Domenech, Anton Vonk Noordegraaf, J Zamorano - European Heart Journal 2009 被引用: 3,858

  10. Patients with pulmonary arterial hypertension with and without cardiovascular risk factors: Results from the AMBITION trial

    著者: , , , , , , , , , , , , , - The Journal of Heart and Lung Transplantation 2019 被引用: 122

  11. Inflammation, Growth Factors, and Pulmonary Vascular Remodeling

    著者: , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2009 被引用: 720

  12. Pulmonary Hypertension in Chronic Lung Diseases

    著者: , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2013 被引用: 679

  13. Survival in pulmonary hypertension in Spain: insights from the Spanish registry

    著者: , , , , , , , , , - European Respiratory Journal 2012 被引用: 415

  14. Pulmonary hypertension in chronic obstructive pulmonary disease

    著者: , , , , , , , - British Journal of Pharmacology 2020 被引用: 98

  15. Defining the clinical validity of genes reported to cause pulmonary arterial hypertension

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rachel L. Damico, Marion Delcroix, Ankit A. Desai, Anna Doboszyńska, C. Gregory Elliott, Mélanie Eyries, Maria Pilar Escribano Subías, Henning Gall, Stefano Ghio, Ardeschir-Hossein Ghofrani, Ekkehard Grünig, Rizwan Hamid, Lars Harbaum, Paul M. Hassoun, Anna R. Hemnes, Katrin Hinderhofer, Luke Howard, Marc Humbert, David G. Kiely, David Langleben, Allan Lawrie, Jim E. Loyd, Shahin Moledina, David Montani, Nichols W. Morrell, William C. Nichols, Andrea Olschewski, Horst Olschewski, Silvia Papa, M. Pauciulo, S. Provencher, Rozenn Quarck, Christopher J. Rhodes, Laura Scelsi, Werner Seeger, Duncan J. Stewart, Andrew J. Sweatt, Emilia M. Swietlik, Carmen Treacy, Richard C. Trembath, Olga Tura-Ceide, Carmine Dario Vizza, Anton Vonk Noordegraaf, Martin R. Wilkins, Roham T. Zamanian, D. A. Zateyshchikov - Genetics in Medicine 2023 被引用: 75

  16. Characterization of pulmonary vascular remodelling in smokers and patients with mild COPD

    著者: , , , , , , - European Respiratory Journal 2002 被引用: 458

  17. An official European Respiratory Society statement: pulmonary haemodynamics during exercise

    著者: , , , , , , , , , , , , , , , , , , , , - European Respiratory Journal 2017 被引用: 303

  18. Standardized exercise training is feasible, safe, and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension: results from a large European multicentre randomized controlled trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Martin Johnson - European Heart Journal 2020 被引用: 123

  19. Oral anticoagulants (NOAC and VKA) in chronic thromboembolic pulmonary hypertension

    著者: , , , , , , , , , , , , - The Journal of Heart and Lung Transplantation 2022 被引用: 66

  20. Pulmonary Hypertension Due to Left Heart Diseases

    著者: , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2013 被引用: 629

  21. Pulmonary vascular density: comparison of findings on computed tomography imaging with histology

    著者: , , , , , , , , , , , , , , - European Respiratory Journal 2019 被引用: 85

  22. Pulmonary hypertension associated with lung diseases

    著者: , , , , , , , , - European Respiratory Journal 2024 被引用: 104

  23. Physiological changes in respiratory function associated with ageing

    著者: , , , , , - European Respiratory Journal 1999 被引用: 663

  24. Elevated plasma levels of epithelial and endothelial cell markers in COVID-19 survivors with reduced lung diffusing capacity six months after hospital discharge

    著者: , , , , , , , , , , , , , - Respiratory Research 2022 被引用: 46